Severe chronic active liver disease. Prognostic significance of initial morphologic patterns. 1977

S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss

To determine the usefulness of recognizing the different morphologic patterns of chronic active liver disease (CALD), we compared clinical and biochemical features as well as responses to treatment in 32 patients with chronic active hepatitis (CAH); 36 with subacute hepatitis and bridging necrosis (SHB); 30 with subacute hepatitis and multilobular necrosis (SHMN); and 30 with cirrhosis and active hepatitis (Cirrh). The morphological lesions did not correlate with clinical or etiologic features. Patients with CAH had less severe biochemical abnormalities, entered remission more often, and failed to respond to treatment less frequently than those with SHMN or Cirrh. SHB and SHMN resembled each other in many regards and showed greater functional changes than CAH. Cirrhosis developed more often after SHMN than CAH and was associated with a poorer prognosis than CAH. Serial liver biopsies revealed all possible histologic transitions, with reduction of inflammation usually occurring in patients treated with steroids and extension of inflammation being more frequent in those not receiving these drugs. CAH, SHB, SHMN, and Cirrh, therefore, reflect the degree and extent of disease activity at any given time in CALD, rather than representing different conditions. Identification of the initial morphologic lesion is helpful because of differences in prognosis.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides

Related Publications

S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
October 1981, Gastroenterology,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
October 1980, Hepato-gastroenterology,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
October 1973, Archives of internal medicine,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
December 1983, Gastroenterologia Japonica,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
February 1992, Hepatology (Baltimore, Md.),
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
April 1981, British journal of haematology,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
August 2018, Hepatology communications,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
July 2006, Cancer,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
January 1971, Transactions of the Association of Life Insurance Medical Directors of America,
S W Schalm, and M G Korman, and W H Summerskill, and A J Czaja, and A H Baggenstoss
July 1972, Journal of the Mississippi State Medical Association,
Copied contents to your clipboard!